Smith & Howard Wealth Management, LLC Amgen Inc Transaction History

Smith & Howard Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $202,081 - $236,762	-952 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $16,350 - $18,139	-70 Reduced 6.85%	952 $232,000
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $2,111 - $2,348	-9 Reduced 0.87%	1,022 $260,000
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $9,297 - $11,408	-47 Reduced 4.36%	1,031 $243,000
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $16,401 - $21,753	-90 Reduced 7.71%	1,078 $219,000
Q4 2019 Jan 13, 2020	BUY	$189.21 - $243.2 $220,997 - $284,057	1,168 New	1,168 $282,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Smith & Howard Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith & Howard Wealth Management, LLC with notifications on news.